These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 8688531)

  • 21. Pharmacokinetic-pharmacodynamic modeling of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in rats.
    Zuideveld KP; Rusiç-Pavletiç J; Maas HJ; Peletier LA; Van der Graaf PH; Danhof M
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1130-7. PubMed ID: 12438536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Development of the serotoninergic system in the mouse midbrain, and the role of serotonin in this process].
    Sapronova AIa; Proshliakova EV; Panaeva VI; Mel'nikova VI; Voronova SN; Ugriumov MV; Turpaev TM
    Biull Eksp Biol Med; 1996 Aug; 122(8):167-9. PubMed ID: 9081468
    [No Abstract]   [Full Text] [Related]  

  • 23. Molecular modeling of buspirone-serotonin receptor interactions.
    Chilmonńczyk Z; Cybulski J; Bronowska A; Leś A
    Acta Pol Pharm; 2000; 57(4):281-8. PubMed ID: 11126617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of lithium oxybutyrate on aggressive animal behavior].
    Zamoshchina TA; Saratikov AS
    Eksp Klin Farmakol; 1996; 59(3):16-9. PubMed ID: 8974576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute and long term effects of buspirone treatments on voluntary ethanol intake in a rat model of alcoholism.
    Hedlund L; Wahlström G
    Alcohol Clin Exp Res; 1999 May; 23(5):822-7. PubMed ID: 10371401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
    Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
    Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced aggression in mice lacking the serotonin transporter.
    Holmes A; Murphy DL; Crawley JN
    Psychopharmacology (Berl); 2002 May; 161(2):160-7. PubMed ID: 11981596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apomorphine-induced upregulation of serotonin 5-HT2A receptors in male rats is independent from development of aggressive behaviour.
    Matto V; Skrebuhhova T; Allikmets L
    J Physiol Pharmacol; 1999 Jun; 50(2):335-44. PubMed ID: 10424728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and anxiolytic activity of N-substituted cyclic imides N-[4-[(4-aryl)-1-piperazinyl]alkyl]-5,7-dioxabicyclo[2.2.2]octane-2, 3-dicarboximide.
    Zawadowski T; Kossakowski J; Rump S; Jakowicz I; Płaźnik A
    Acta Pol Pharm; 1995; 52(1):43-6. PubMed ID: 8960237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose related effects of buspirone on serum electrolyte balance, plasma osmolality and systolic blood pressure (SBP) in rats.
    Farooq R; Haleem DJ; Haleem MA
    Pak J Pharm Sci; 2007 Oct; 20(4):295-9. PubMed ID: 17604252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical stimulation of the rat midbrain and aggressive behaviour.
    Bandler RJ
    Nat New Biol; 1971 Feb; 229(7):222-3. PubMed ID: 5281024
    [No Abstract]   [Full Text] [Related]  

  • 32. Buspirone alone or with serotonergic diet reduced aggression in a developmentally disabled adult.
    Gedye A
    Biol Psychiatry; 1991 Jul; 30(1):88-91. PubMed ID: 1892965
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy of buspirone in the treatment of dementia with aggression.
    Holzer JC; Gitelman DR; Price BH
    Am J Psychiatry; 1995 May; 152(5):812. PubMed ID: 7726330
    [No Abstract]   [Full Text] [Related]  

  • 34. Can dietary intervention help in management of problem behaviors in dementia?
    Volicer L
    J Nutr Health Aging; 2009 Jun; 13(6):499-501. PubMed ID: 19536418
    [No Abstract]   [Full Text] [Related]  

  • 35. Buspirone and electroencephalography.
    Barbanoj MJ; Antonijoan RM; Jané F
    Clin Pharmacol Ther; 1995 Jun; 57(6):699. PubMed ID: 7781271
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dependence of the anti-aggression properties of buspirone on time of day].
    Zamoshchina TA; Ladyzhets EN; Saratikov AS
    Biull Eksp Biol Med; 1996 Mar; 121(3):291-4. PubMed ID: 8688531
    [No Abstract]   [Full Text] [Related]  

  • 37. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.
    Millan MJ; Hjorth S; Samanin R; Schreiber R; Jaffard R; De Ladonchamps B; Veiga S; Goument B; Peglion JL; Spedding M; Brocco M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):148-61. PubMed ID: 9223550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neonatal buspirone modulates the intermale aggression in adult mice].
    Markina NV; Perepelkina OV; Bizikoeva FZ; Fedotova IB; Kovalev GI; Poletaev II
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2006; 56(4):491-8. PubMed ID: 17025193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF; Koolhaas JM
    Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.